Effect of neoadjuvant chemotherapy on the overall treatment strategy in operable breast cancer
10.3760/cma.j.issn.0253-3766.2017.12.014
- VernacularTitle: 新辅助化疗对可手术乳腺癌患者总体治疗策略影响的思考
- Author:
Wenshu ZUO
1
;
Meizhu ZHENG
1
;
Chao HAN
1
Author Information
1. Department of SurgeryⅡ, Shandong Breast Center of Prevention and Treatment, Shandong Cancer Hospital Affiliated to Shandong University, Shandong Academy of Medical Sciences, Jinan 250117, China
- Publication Type:Journal Article
- Keywords:
Breast neoplasms;
Neoadjuvant chemotherapy;
Treatment strategies
- From:
Chinese Journal of Oncology
2017;39(12):952-957
- CountryChina
- Language:Chinese
-
Abstract:
The intention of neoadjuvant chemotherapy in breast cancer is to shrink the tumors in locally advanced disease and to improve the degree of cure of operation (security). Therefore, it is expected to improve quality of life and survival for patients. Additionally, neoadjuvant chemotherapy is administered based on the observable primary tumor. Thus, the timely assessment of tumor response to chemotherapeutic drugs provides a basis for subsequent treatment. Currently, however, the treatment concept of breast cancer requires whole process management. It requires clinicians to develop the overall treatment strategy according to tumor biological information of patients, as well as timely and reasonable adjustment of the subsequent treatment based on the response to neoadjuvant chemotherapy. These are new problems arising from neoadjuvant chemotherapy.